Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Philip Merritt

Adult Reconstructive Orthopaedic Surgery Glendale, CA Medical Doctor

NPI 1083696074 CMS profile 393866

1505 Wilson Ter, Suite 200, Glendale, CA 91206

Open in the dashboard

General payments

$449,674

86 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$192,800

7 holdings reported · through program year 2025

Through program year 2025, Philip Merritt of Glendale, CA is reported in the CMS Open Payments database as having received $449,674 across 86 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $192,800 across 7 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,939 5
2024 General $265 3
2023 General $11,565 13
2022 General $26,463 9
2021 General $104,709 13
2020 General $139,181 16
2019 General $160,552 27
2025 Ownership $35,316 1
2024 Ownership $35,316 1
2023 Ownership $35,964 1
2022 Ownership $35,964 1
2021 Ownership $23,940 1
2020 Ownership $13,300 1
2019 Ownership $13,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Philip Merritt
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Philip Merritt were reported at $6,939. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Philip Merritt Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $160,552 $1,416 $292–$9,336 $163
2020 $139,181 $647 $141–$6,474 $114
2021 $104,709 $1,073 $211–$6,497 $132
2022 $26,463 $1,217 $236–$6,299 $149
2023 $11,565 $1,082 $246–$6,818 $160
2024 $265 $1,575 $323–$8,944 $164
2025 $6,939 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $305,953 23 payments
  2. Encore Medical, LP $109,969 31 payments
  3. Applied Medical Corporation $26,035 4 payments
  4. Uoc USA Inc $6,939 5 payments
  5. Stryker Corporation $317 4 payments
  6. Engage Uni, LLC $114 1 payment
  7. Amgen Inc. $76 4 payments
  8. Flexion Therapeutics, Inc. $51 2 payments
  9. Misonix Inc $40 1 payment
  10. Boston Scientific Corporation $30 1 payment
  11. Other $149 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $399,118 20 payments
  2. Consulting Fee $24,645 10 payments
  3. Travel and Lodging $13,233 8 payments
  4. Current or prospective ownership or investment interest $10,640 1 payment
  5. Food and Beverage $1,924 46 payments
  6. Gift $114 1 payment
Products named General payments · program years 2019–2025
  1. Echo Hips $188,286 8 payments
  2. DJO Surgical TaperFill Hip System $99,207 10 payments
  3. Echo Hips $93,665 4 payments
  4. Echo Hips $23,074 1 payment
  5. UTS, Conformity, U-MII, U2 Revision Stem, PSA, USTAR, U2 Knee $6,874 4 payments
  6. DJO SURGICAL Joint Implants $6,498 7 payments
  7. DJO SURGICAL Joint Implants $3,193 5 payments
  8. DJO Surgical 3DKnee System $786 2 payments
  9. ROSA $556 2 payments
  10. MAKO $286 3 payments
  11. Other $1,421 40 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

1,430

Median for Orthopedic Surgery: 203

Drug cost

$47,426

Median for Orthopedic Surgery: $1,433

Branded share of claims

19.4%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 995 $29,669
Diclofenac Sodium Generic 35 $15,919
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 145 $970
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 118 $243
Doxycycline Hyclate Generic 20 $179
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 15 $93
Ezetimibe Generic 13 $77
Methylprednisolone Generic 15 $69
Gabapentin Generic 12 $63
Amoxicillin Generic 25 $58

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 53 billing codes

Paid by Medicare

$467,732

Medicare's payments for the services billed

Medicare patients

899

Average age 75

Services billed

2,198

678 women, 221 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 59%
Ischemic heart disease 57%
Depression 48%
Osteoporosis 36%
Heart failure 29%
Chronic kidney disease 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Activase
  • Genentech USA, Inc. $18
$18 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

86 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record